Cargando…

Concurrent Disorder Management Guidelines. Systematic Review

Concurrent disorder refers to a diverse set of combinations of substance use disorders and mental disorders simultaneously in need of treatment. Concurrent disorders are underdiagnosed, undertreated, and more complex to manage, practicing the best recommendations can support better outcomes. The pur...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakobyan, Syune, Vazirian, Sara, Lee-Cheong, Stephen, Krausz, Michael, Honer, William G., Schutz, Christian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463987/
https://www.ncbi.nlm.nih.gov/pubmed/32731398
http://dx.doi.org/10.3390/jcm9082406
_version_ 1783577260520898560
author Hakobyan, Syune
Vazirian, Sara
Lee-Cheong, Stephen
Krausz, Michael
Honer, William G.
Schutz, Christian G.
author_facet Hakobyan, Syune
Vazirian, Sara
Lee-Cheong, Stephen
Krausz, Michael
Honer, William G.
Schutz, Christian G.
author_sort Hakobyan, Syune
collection PubMed
description Concurrent disorder refers to a diverse set of combinations of substance use disorders and mental disorders simultaneously in need of treatment. Concurrent disorders are underdiagnosed, undertreated, and more complex to manage, practicing the best recommendations can support better outcomes. The purpose of this work is to systematically assess the quality of the current concurrent disorders’ clinical recommendation management guidelines. Literature searches were performed by two independent authors in electronic databases, web, and gray literature. The inclusion criteria were English language clinical management guidelines for adult concurrent disorders between 2000 and 2020. The initial search resulted in 8841 hits. A total of 24 guidelines were identified and assessed with the standardized guidelines assessment tool: AGREE II (Appraisal of Guidelines for Research and Evaluation). Most guidelines had acceptable standards, however, only the NICE guidelines had all detailed information on all AGREE II Domains. Guidelines generally supported combinations of treatments for individual disorders with a very small evidence base for concurrent disorders, and they provided little recommendation for further structuring of the field, such as level of complexity or staging, or evaluating different models of treatment integration.
format Online
Article
Text
id pubmed-7463987
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74639872020-09-04 Concurrent Disorder Management Guidelines. Systematic Review Hakobyan, Syune Vazirian, Sara Lee-Cheong, Stephen Krausz, Michael Honer, William G. Schutz, Christian G. J Clin Med Review Concurrent disorder refers to a diverse set of combinations of substance use disorders and mental disorders simultaneously in need of treatment. Concurrent disorders are underdiagnosed, undertreated, and more complex to manage, practicing the best recommendations can support better outcomes. The purpose of this work is to systematically assess the quality of the current concurrent disorders’ clinical recommendation management guidelines. Literature searches were performed by two independent authors in electronic databases, web, and gray literature. The inclusion criteria were English language clinical management guidelines for adult concurrent disorders between 2000 and 2020. The initial search resulted in 8841 hits. A total of 24 guidelines were identified and assessed with the standardized guidelines assessment tool: AGREE II (Appraisal of Guidelines for Research and Evaluation). Most guidelines had acceptable standards, however, only the NICE guidelines had all detailed information on all AGREE II Domains. Guidelines generally supported combinations of treatments for individual disorders with a very small evidence base for concurrent disorders, and they provided little recommendation for further structuring of the field, such as level of complexity or staging, or evaluating different models of treatment integration. MDPI 2020-07-28 /pmc/articles/PMC7463987/ /pubmed/32731398 http://dx.doi.org/10.3390/jcm9082406 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hakobyan, Syune
Vazirian, Sara
Lee-Cheong, Stephen
Krausz, Michael
Honer, William G.
Schutz, Christian G.
Concurrent Disorder Management Guidelines. Systematic Review
title Concurrent Disorder Management Guidelines. Systematic Review
title_full Concurrent Disorder Management Guidelines. Systematic Review
title_fullStr Concurrent Disorder Management Guidelines. Systematic Review
title_full_unstemmed Concurrent Disorder Management Guidelines. Systematic Review
title_short Concurrent Disorder Management Guidelines. Systematic Review
title_sort concurrent disorder management guidelines. systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463987/
https://www.ncbi.nlm.nih.gov/pubmed/32731398
http://dx.doi.org/10.3390/jcm9082406
work_keys_str_mv AT hakobyansyune concurrentdisordermanagementguidelinessystematicreview
AT vaziriansara concurrentdisordermanagementguidelinessystematicreview
AT leecheongstephen concurrentdisordermanagementguidelinessystematicreview
AT krauszmichael concurrentdisordermanagementguidelinessystematicreview
AT honerwilliamg concurrentdisordermanagementguidelinessystematicreview
AT schutzchristiang concurrentdisordermanagementguidelinessystematicreview